Krugmann J, Dirnhofer S, Gschwendtner A, Berresheim U, Greil R, Krugmann K, Fend F
Department of Pathology, University of Innsbruck, Austria.
Pathol Res Pract. 2001;197(6):385-93. doi: 10.1078/0344-0338-00051.
We hereby present a retrospective clinicopathological and immunohistochemical study of surgically resected primary gastrointestinal (GI) lymphoma with an analysis of parameters of potential prognostic relevance. From a larger series of 144 cases of primary GI lymphomas, we chose 61 cases with sufficient clinical follow-up (mean 60, range 1-219 months), classified either as extranodal marginal zone B-cell lymphoma of MALT type (MALT lymphoma) or diffuse large B-cell lymphoma (DLBCL), after having excluded other subtypes. In addition to conventional clinical and morphological parameters, the expression levels of Ki-67 (MIB-1), bcl-2 and p53 were evaluated for prognostic significance. Twenty-one (34.4%) cases were classified as pure low grade marginal zone B-cell lymphoma of MALT type, 12 (19.7%) cases as low grade MALT lymphoma with a high grade component (mixed type), and 28 (45.9%) cases as primary extranodal DLBCL. Most of the lymphomas (53/61; 86.9%) were localized in the stomach, 3 (4.9%) in the small bowel, 3 (4.9%) multifocal in both stomach and small intestine and 2 (3.3%) in the large bowel. MIB-1 expression in more than 30% of tumor cells was detected in 42 (68.6%), bcl-2 expression in 20 (32.8%) and p53 accumulation in more than 10% of neoplastic cells in 16 (26.2%) lymphomas. Both high Ki-67 expression and p53 accumulation were more prevalent in the DLBCL. 30 (49%) patients showed lymph node involvement at surgery, 14 (23%) patients suffered tumor recurrence, and 24 (38.5%) died during the follow-up period. Tumor recurrence occurred primarily in patients who had presented lymph node involvement (9/14, 64.3%). The 5-year survival rate was 66.1% for all patients. Important prognostic factors for overall survival were tumor stage (p < .004) and p53 accumulation (p < .05) in univariate analysis, and tumor stage in multivariate analysis (p < .001). Although p53 accumulation did not reach statistical significance in our small study group, it may be both important in the transformation of low grade MALT lymphoma and an indicator for aggressive behavior in high grade tumors.
我们在此展示一项对手术切除的原发性胃肠道(GI)淋巴瘤的回顾性临床病理及免疫组织化学研究,并分析潜在预后相关参数。在144例原发性GI淋巴瘤的较大系列病例中,我们选择了61例有充分临床随访(平均60个月,范围1 - 219个月)的病例,在排除其他亚型后,分类为黏膜相关淋巴组织型(MALT)结外边缘区B细胞淋巴瘤(MALT淋巴瘤)或弥漫性大B细胞淋巴瘤(DLBCL)。除了常规临床和形态学参数外,还评估了Ki-67(MIB-1)、bcl-2和p53的表达水平以判断预后意义。21例(34.4%)病例分类为单纯低级别MALT型边缘区B细胞淋巴瘤,12例(19.7%)病例为具有高级别成分的低级别MALT淋巴瘤(混合型),28例(45.9%)病例为原发性结外DLBCL。大多数淋巴瘤(53/61;86.9%)位于胃,3例(4.9%)位于小肠,3例(4.9%)在胃和小肠均为多灶性,2例(3.3%)位于大肠。42例(68.6%)淋巴瘤检测到超过30%肿瘤细胞表达MIB-1,20例(32.8%)表达bcl-2,16例(26.2%)淋巴瘤超过10%肿瘤细胞有p53积聚。高Ki-67表达和p53积聚在DLBCL中更为常见。30例(49%)患者手术时出现淋巴结受累,14例(23%)患者发生肿瘤复发,24例(38.5%)患者在随访期间死亡。肿瘤复发主要发生在出现淋巴结受累的患者中(9/14,64.3%)。所有患者的5年生存率为66.1%。单因素分析中,总体生存的重要预后因素为肿瘤分期(p <.004)和p53积聚(p <.05),多因素分析中为肿瘤分期(p <.001)。尽管在我们的小研究组中p53积聚未达到统计学意义,但它可能在低级别MALT淋巴瘤的转化中很重要,并且是高级别肿瘤侵袭性行为的一个指标。